Enterohemorrhagic Escherichia coli O157:H7 antigens produced in transgenic lettuce effective as an oral vaccine in mice
Authors:
- 23 September 2023
- journal article
- research article
- Published by Springer Nature in Theoretical and Applied Genetics
- Vol. 136 (10) , 1-14
Abstract
Key message Transgene with recombination sites to address biosafety concerns engineered into lettuce to produce EspB and γ-intimin C280 for oral vaccination against EHEC O157:H7. Abstract Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a food-borne pathogen where ruminant farm animals, mainly bovine, serve as reservoirs. Bovine vaccination has been used to prevent disease outbreaks, and the current method relies on vaccines subcutaneously injected three times per year. Since EHEC O157:H7 colonizes mucosal surfaces, an oral vaccine that produces an IgA response could be more convenient. Here, we report on oral vaccination against EHEC O157:H7 in mice orally gavaged with transgenic lettuce that produces EHEC O157:H7 antigens EspB and γ-intimin C280. Younger leaves accumulated a higher concentration of antigens; and in unexpanded leaves of 30-day-old T2 plants, EspB and γ-intimin C280 were up to 32 and 51 μg/g fresh weight, respectively. Mice orally gavaged with lettuce powders containing < 3 µg antigens for 6 days showed a mucosal immune response with reduced colonization of EHEC O157:H7. This suggests that the transgenic lettuce has potential to be used for bovine vaccination. To promote the biosafety of crop plants producing medically relevant proteins, recombination sites were built into our transgenic lines that would permit optional marker removal by Cre-lox recombination, as well as transgene deletion in pollen by CinH-RS2 recombination. The ability to upgrade the transgenic lettuce by stacking additional antigen genes or replacing older genes with newer versions would also be possible through the combined use of Bxb-att and Cre-lox recombination systems.Keywords
Funding Information
- Guangdong Basic and Applied Basic Research Foundation (2020A1515110765)
- the National key R&D Project (2016YFD0101904)
- Key Project of Frontier Science Research of Chinese Academy of Sciences (QYZDY-SSW-SMC010)
- National Science and Technology Promotion Agency (PICT-2018-02280)
This publication has 56 references indexed in Scilit:
- Predicting the public health benefit of vaccinating cattle against Escherichia coli O157Proceedings of the National Academy of Sciences, 2013
- Immunization of sheep with a combination of intiminγ, EspA and EspB decreases Escherichia coli O157:H7 sheddingVeterinary Immunology and Immunopathology, 2011
- Low‐cost production of proinsulin in tobacco and lettuce chloroplasts for injectable or oral delivery of functional insulin and C‐peptidePlant Biotechnology Journal, 2010
- Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulationJournal of Applied Genetics, 2010
- Bovine Colostrum Contains Immunoglobulin G Antibodies against Intimin, EspA, and EspB and Inhibits Hemolytic Activity Mediated by the Type Three Secretion System of Attaching and Effacing Escherichia coliClinical and Vaccine Immunology, 2008
- Pollen‐mediated transgene flow in lettuce (Lactuca sativa L.)Plant Breeding, 2008
- Management of diarrhea-associated hemolytic uremic syndrome in childrenClinical and Experimental Nephrology, 2008
- Isotype-specific antibody responses against Escherichia coli O157:H7 locus of enterocyte effacement proteins in adult beef cattle following experimental infectionVeterinary Immunology and Immunopathology, 2007
- A plant-based oral vaccine to protect against systemic intoxication by Shiga toxin type 2Proceedings of the National Academy of Sciences, 2006
- Escherichia coliO157:H7 Hemorrhagic ColitisNew England Journal of Medicine, 1988